| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 183,662 | 186,280 | 204,753 | | Cost of Revenue | 133,110 | 138,819 | 142,551 | | | Gross Profit | 50,552 | 47,461 | 62,202 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 59,371 | 64,415 | 63,429 | | Non Recurring | 2,957 | (1,567) | 333 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (11,776) | (15,387) | (1,560) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 121 | 115 | 112 | | Earnings Before Interest And Taxes | (11,656) | (15,272) | (1,448) | | Interest Expense | 3,255 | 1,694 | 1,005 | | Income Before Tax | (14,911) | (16,966) | (2,453) | | Income Tax Expense | 85 | 691 | (910) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,996) | (17,657) | (1,543) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,996) | (17,657) | (1,543) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,996) | ($17,657) | ($1,543) |
|
1.00% Nasdaq 0.00%
Income Statement
